Brief: Immunovia CEO Patrik Dahlen Buys 6,860 Shares In Co
May 28 (Reuters) - Immunovia AB (publ) IMMNOV.ST :
* CEO PATRIK DAHLEN PURCHASES IMMUNOVIA SHARES
* PATRIK DAHLEN, CEO OF IMMUNOVIA, HAS PURCHASED 6,860
SHARES FOR
APPROXIMATELY SEK 675,000 OVER STOCK EXCHANGE
* HIS TOTAL HOLDING NOW AMOUNTS TO 51,860 SHARES IN
IMMUNOVIA
Source text for Eikon: ID:nWkr1tWrNS
Further company coverage: IMMNOV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study